Back to today’s briefing

Story perspectives

FDA Ends Weight-Loss Drug Shortage, States Target Counterfeits

3/4/2025

26 2

Summary

Story summary

The FDA has officially ended the shortage of popular weight-loss medications like Ozempic and Wegovy, forcing local pharmacies to stop making their own versions by April and May. Meanwhile, nearly 40 state Attorneys General are rallying against counterfeit drugs that threaten consumer safety, urging patients to seek guidance from healthcare professionals.

1 of 1

Story summary

The FDA has officially ended the shortage of popular weight-loss medications like Ozempic and Wegovy, forcing local pharmacies to stop making their own versions by April and May. Meanwhile, nearly 40 state Attorneys General are rallying against counterfeit drugs that threaten consumer safety, urging patients to seek guidance from healthcare professionals.